Revvity Inc. $RVTY Shares Sold by IFM Investors Pty Ltd

IFM Investors Pty Ltd lessened its holdings in Revvity Inc. (NYSE:RVTY) by 2.8% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 22,943 shares of the company’s stock after selling 652 shares during the period. IFM Investors Pty Ltd’s holdings in Revvity were worth $2,219,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. T. Rowe Price Investment Management Inc. increased its position in shares of Revvity by 8.5% in the 1st quarter. T. Rowe Price Investment Management Inc. now owns 22,515,711 shares of the company’s stock worth $2,382,163,000 after purchasing an additional 1,754,403 shares during the last quarter. Vanguard Group Inc. grew its position in Revvity by 0.6% in the 1st quarter. Vanguard Group Inc. now owns 14,382,849 shares of the company’s stock worth $1,521,705,000 after purchasing an additional 92,638 shares during the last quarter. Price T Rowe Associates Inc. MD grew its position in Revvity by 25.3% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 9,563,911 shares of the company’s stock worth $1,011,863,000 after purchasing an additional 1,932,314 shares during the last quarter. EdgePoint Investment Group Inc. lifted its stake in shares of Revvity by 32.1% in the 1st quarter. EdgePoint Investment Group Inc. now owns 5,360,847 shares of the company’s stock worth $567,178,000 after acquiring an additional 1,302,616 shares during the period. Finally, Mitsubishi UFJ Asset Management Co. Ltd. lifted its stake in shares of Revvity by 1.8% in the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 3,444,645 shares of the company’s stock worth $364,443,000 after acquiring an additional 62,307 shares during the period. Hedge funds and other institutional investors own 86.65% of the company’s stock.

Wall Street Analyst Weigh In

RVTY has been the subject of several recent research reports. Wall Street Zen lowered shares of Revvity from a “buy” rating to a “hold” rating in a research note on Sunday, August 3rd. Raymond James Financial restated an “outperform” rating and set a $115.00 price target (down previously from $120.00) on shares of Revvity in a research note on Tuesday, July 29th. Stifel Nicolaus reduced their price target on shares of Revvity from $120.00 to $110.00 and set a “hold” rating for the company in a report on Tuesday, July 29th. Bank of America reduced their price target on shares of Revvity from $110.00 to $99.00 and set a “buy” rating for the company in a report on Monday. Finally, Evercore ISI reduced their price objective on shares of Revvity from $116.00 to $115.00 and set an “outperform” rating for the company in a report on Tuesday, July 8th. Ten investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $119.29.

Revvity Price Performance

NYSE RVTY opened at $86.38 on Tuesday. The company has a quick ratio of 2.75, a current ratio of 3.33 and a debt-to-equity ratio of 0.43. Revvity Inc. has a 12-month low of $81.36 and a 12-month high of $129.50. The company has a market capitalization of $10.03 billion, a PE ratio of 36.60, a price-to-earnings-growth ratio of 2.33 and a beta of 0.94. The firm’s 50 day moving average is $89.79 and its 200-day moving average is $94.85.

Revvity (NYSE:RVTY) last posted its quarterly earnings data on Monday, July 28th. The company reported $1.18 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.14 by $0.04. The company had revenue of $720.28 million for the quarter, compared to the consensus estimate of $711.26 million. Revvity had a net margin of 10.19% and a return on equity of 7.66%. The firm’s revenue was up 4.1% compared to the same quarter last year. During the same period last year, the company earned $1.22 earnings per share. Revvity has set its FY 2025 guidance at 4.850-4.950 EPS. Equities research analysts anticipate that Revvity Inc. will post 4.94 earnings per share for the current fiscal year.

Revvity Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, November 7th. Investors of record on Friday, October 17th will be issued a dividend of $0.07 per share. This represents a $0.28 dividend on an annualized basis and a yield of 0.3%. The ex-dividend date is Friday, October 17th. Revvity’s payout ratio is presently 11.86%.

Revvity Company Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.